1. Home
  2. NVNI vs VVOS Comparison

NVNI vs VVOS Comparison

Compare NVNI & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nvni Group Limited

NVNI

Nvni Group Limited

HOLD

Current Price

$1.62

Market Cap

15.4M

Sector

N/A

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$1.54

Market Cap

17.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVNI
VVOS
Founded
2019
2016
Country
Brazil
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4M
17.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NVNI
VVOS
Price
$1.62
$1.54
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
165.1K
138.2K
Earning Date
09-30-2025
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,577,595.00
$17,317,000.00
Revenue This Year
$6.67
$28.86
Revenue Next Year
$26.67
$48.70
P/E Ratio
N/A
N/A
Revenue Growth
14.38
18.76
52 Week Low
$1.43
$1.42
52 Week High
$40.50
$7.95

Technical Indicators

Market Signals
Indicator
NVNI
VVOS
Relative Strength Index (RSI) 33.31 36.90
Support Level $1.43 $1.42
Resistance Level $1.85 $1.88
Average True Range (ATR) 0.20 0.14
MACD 0.01 0.01
Stochastic Oscillator 25.73 21.14

Price Performance

Historical Comparison
NVNI
VVOS

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: